Mackenzie Financial Corp Shockwave Medical, Inc. Transaction History

Mackenzie Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$194.33 - $283.97 $6,995 - $10,222	36 Added 0.54%	6,701 $1.33 Million
Q2 2023 Aug 03, 2023	BUY	$223.05 - $302.68 $17,174 - $23,306	77 Added 1.17%	6,665 $1.9 Million
Q1 2023 Apr 24, 2023	BUY	$175.41 - $217.92 $288,900 - $358,914	1,647 Added 33.33%	6,588 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $1.01 Million - $1.47 Million	4,941 New	4,941 $1.02 Million
Q2 2022 Aug 10, 2022	SELL	$115.91 - $214.48 $281,429 - $520,757	-2,428 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$127.96 - $207.36 $76,136 - $123,379	595 Added 32.46%	2,428 $503,000
Q4 2021 Feb 14, 2022	SELL	$165.13 - $241.83 $12,384 - $18,137	-75 Reduced 3.93%	1,833 $327,000
Q3 2021 Nov 08, 2021	BUY	$163.99 - $235.57 $125,616 - $180,446	766 Added 67.08%	1,908 $393,000
Q2 2021 Aug 11, 2021	BUY	$131.45 - $201.49 $150,115 - $230,101	1,142 New	1,142 $217,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.